Table 1.

Laboratory characteristics of the participants

Variables	ovarian cancer	benign ovarian tumors	controls	P-value
Number	326	290	162
Age(years)	43.15 ± 11.59	43.18 ± 9.25	44.13 ± 6.90	0.544
W; (109/L)	8.28 ± 4.01a	6.69 ± 2.25	6.33 ± 1.49c	<0.001
N; (109/L)	6.11 ± 4.04a	4.12 ± 2.01	3.70 ± 1.12c	<0.001
L; (109/L)	1.52 ± 0.68a	1.97 ± 0.67	2.07 ± 0.72c	<0.001
Mo; (109/L)	0.49 ± 0.01a	0.45 ± 0.15	0.44 ± 0.15c	0.001
Hb; (g/L)	106.38 ± 19.53a	124.64 ± 13.13	128.14 ± 6.47c	<0.001
PLT; (1012/L)	216.50 ± 130.92a	239.68 ± 88.08	248.18 ± 64.8c	0.001
MPV; (fl)	8.19 ± 0.86a	9.31 ± 0.91b	9.64 ± 0.63c	<0.001
PDW;(%)	0.16 ± 0.01a	0.16 ± 0.02b	0.16 ± 0.01c	<0.001
RDW;(%)	0.16 ± 0.02a	0.14 ± 0.01b	0.13 ± 0.01c	<0.001
CA125; U/mL	68.85(32.20–385.05)a	23.15(14.43–37.76)	5.94(4.04–13.94)c	<0.001

Data are expressed as mean ± standard deviation or median (interquartile range)

W, white blood cell count; N, absolute neutrophil count; L, absolute lymphocyte count; Mo, absolute monocyte count; Hb, hemoglobin; PLT, blood platelet count; MPV, mean platelet volume; PDW, platelet distribution width; RDW, red cell distribution width; CA125, cancer antigen 125

P values were calculated by one-way ANOVA tests

^aIndicates a significant difference (P < 0.05) between ovarian cancer and benign ovarian tumors (Tukey’s test)

^bIndicates a significant difference (P < 0.05) between benign ovarian tumors and controls (Tukey’s test)

^cIndicates a significant difference (P < 0.05) between ovarian cancer and controls (Tukey’s test)

10⁹,10^{^}9; 10¹²,10^{^}12